XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue        
Total revenue $ 1,239,132 $ 1,056,765 $ 2,880,463 $ 2,862,083
Operating expenses        
Research and development 2,382,303 2,433,553 8,055,384 6,630,134
General and administrative 2,088,226 2,356,413 7,444,138 6,549,432
Sales and marketing 1,003,577 932,671 2,705,378 2,258,980
Transaction costs 470,322
Impairment of right-of-use asset 170,714
Impairment of intangibles assets 750,596
Total operating expenses 6,325,718 7,232,727 20,366,778 19,550,345
Operating loss (5,086,586) (6,175,962) (17,486,315) (16,688,262)
Other (expense) income        
Gain on extinguishment of debt 259,353
Warrant inducement expense (7,755,541)
Interest and other income, net 31,844 19,965 41,471 101,644
Interest expense (1,222,867) (1,183,927) (3,586,018) (2,267,085)
Foreign currency transaction (losses) gains 229,074 (501,168) 655,774 (794,832)
Change in fair value of derivative financial instruments (8,161) 165,497 (122,572) 548,008
Total other (expense) income (970,110) (1,499,633) (10,507,533) (2,412,265)
Loss before income taxes (6,056,696) (7,675,595) (27,993,848) (19,100,527)
Provision for income taxes
Net loss (6,056,696) (7,675,595) (27,993,848) (19,100,527)
Net loss available to common stockholders $ (6,056,696) $ (7,675,595) $ (27,993,848) $ (19,100,527)
Net loss per common share - basic and diluted $ (0.16) $ (0.40) $ (0.79) $ (1.36)
Weighted average shares outstanding - basic and diluted 38,270,250 19,116,864 35,373,397 14,016,896
Net loss $ (6,056,696) $ (7,675,595) $ (27,993,848) $ (19,100,527)
Other comprehensive income (loss) - foreign currency translation (597,527) 1,266,901 (1,146,355) 1,631,317
Comprehensive loss (6,654,223) (6,408,694) (29,140,203) (17,469,210)
Product sales [Member]        
Revenue        
Total revenue 643,887 601,562 1,479,270 1,569,799
Operating expenses        
Cost of products and services 648,298 1,350,296 1,544,932 2,340,766
Laboratory services [Member]        
Revenue        
Total revenue 192,753 112,892 643,602 138,884
Operating expenses        
Cost of products and services 203,314 159,794 446,232 550,115
Collaborations revenue [Member]        
Revenue        
Total revenue $ 402,492 $ 342,311 $ 757,591 $ 1,153,400